REGENXBIO (RGNX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

REGENXBIO Revenue Highlights

Latest Revenue (Y)

$83.33M

Latest Revenue (Q)

$21.36M

Main Segment (Y)

License and Service

REGENXBIO Revenue by Period

REGENXBIO Revenue by Year

Date	Revenue	Change
2024-12-31	$83.33M	-7.66%
2023-12-31	$90.24M	-19.94%
2022-12-31	$112.72M	-76.03%
2021-12-31	$470.35M	204.30%
2020-12-31	$154.57M	338.70%
2019-12-31	$35.23M	-83.88%
2018-12-31	$218.50M	2002.42%
2017-12-31	$10.39M	126.48%
2016-12-31	$4.59M	-39.52%
2015-12-31	$7.59M	23.99%
2014-12-31	$6.12M	0.54%
2013-12-31	$6.09M	-

REGENXBIO generated $83.33M in revenue during NA 2024, up -7.66% compared to the previous quarter, and up 236.51% compared to the same period a year ago.

REGENXBIO Revenue by Quarter

Date	Revenue	Change
2025-06-30	$21.36M	-76.00%
2025-03-31	$89.01M	319.59%
2024-12-31	$21.21M	-12.33%
2024-09-30	$24.20M	8.53%
2024-06-30	$22.30M	42.72%
2024-03-31	$15.62M	-29.67%
2023-12-31	$22.21M	-23.18%
2023-09-30	$28.91M	44.74%
2023-06-30	$19.98M	4.38%
2023-03-31	$19.14M	-38.94%
2022-12-31	$31.34M	18.23%
2022-09-30	$26.51M	-18.80%
2022-06-30	$32.65M	46.95%
2022-03-31	$22.22M	-94.43%
2021-12-31	$398.65M	1195.47%
2021-09-30	$30.77M	39.66%
2021-06-30	$22.04M	16.69%
2021-03-31	$18.88M	-11.94%
2020-12-31	$21.45M	-78.32%
2020-09-30	$98.91M	497.08%
2020-06-30	$16.57M	-6.11%
2020-03-31	$17.64M	49.93%
2019-12-31	$11.77M	-19.95%
2019-09-30	$14.70M	86.52%
2019-06-30	$7.88M	791.52%
2019-03-31	$884.00K	-97.83%
2018-12-31	$40.78M	668.51%
2018-09-30	$5.31M	-86.75%
2018-06-30	$40.03M	-69.76%
2018-03-31	$132.39M	6389.75%
2017-12-31	$2.04M	52.69%
2017-09-30	$1.34M	-79.64%
2017-06-30	$6.56M	1342.20%
2017-03-31	$455.00K	-73.17%
2016-12-31	$1.70M	1256.80%
2016-09-30	$125.00K	-94.74%
2016-06-30	$2.38M	504.33%
2016-03-31	$393.00K	-91.16%
2015-12-31	$4.45M	290.18%
2015-09-30	$1.14M	-16.36%
2015-06-30	$1.36M	111.65%
2015-03-31	$644.00K	-43.90%
2014-12-31	$1.15M	137.68%
2014-09-30	$483.00K	-

REGENXBIO generated $21.36M in revenue during Q2 2025, up -76.00% compared to the previous quarter, and up 136.72% compared to the same period a year ago.

REGENXBIO Revenue Breakdown

REGENXBIO Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
License and Service	$83.33M	$90.24M	$112.72M	-	-
License And Service	-	-	-	$470.35M	$154.57M

REGENXBIO's latest annual revenue breakdown by segment (product or service), as of Dec 24: License and Service (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
License and Service	$18.46M	$87.05M	$21.21M	$24.20M	$22.30M	$15.62M	$70.27M	$19.98M	$31.34M	-	-	-	-	-	-	-	-	-	-	-
Service	$2.89M	$1.96M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License And Service	-	-	-	-	-	-	-	-	$19.14M	$26.51M	$32.65M	$22.22M	$398.65M	$30.77M	$22.04M	$18.88M	-	-	-	-
License	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.50M
Zolgensma Royalties	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$20.91M	$18.80M	$11.95M
Achievement Of Sales Based Milestone For Zolgensma	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$80.00M	-

REGENXBIO's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: License and Service (86.45%), and Service (13.55%).

REGENXBIO Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PRTA	Prothena	$135.16M	$4.42M
GOSS	Gossamer Bio	$114.70M	$11.49M
RGNX	REGENXBIO	$83.33M	$21.36M
BCYC	Bicycle Therapeutics	$35.27M	$9.98M
MGTX	MeiraGTx	$33.28M	$1.93M
VSTM	Verastem	$10.00M	-
QSI	Quantum-Si	$3.06M	$591.00K
SVRA	Savara	-	-
KALV	KalVista Pharmaceuticals	-	$1.43M
MLTX	MoonLake Immunotherapeutics	-	-
OMER	Omeros	-	-

RGNX Revenue FAQ

What is REGENXBIO’s yearly revenue?

REGENXBIO's yearly revenue for 2024 was $83.33M, representing a decrease of -7.66% compared to 2023. The company's yearly revenue for 2023 was $90.24M, representing a decrease of -19.94% compared to 2022. RGNX's yearly revenue for 2022 was $112.72M, representing a decrease of -76.03% compared to 2021.

What is REGENXBIO’s quarterly revenue?

REGENXBIO's quarterly revenue for Q2 2025 was $21.36M, a -76.00% decrease from the previous quarter (Q1 2025), and a -4.20% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $89.01M, a 319.59% increase from the previous quarter (Q4 2024), and a 469.79% increase year-over-year (Q1 2024). RGNX's quarterly revenue for Q4 2024 was $21.21M, a -12.33% decrease from the previous quarter (Q3 2024), and a -4.50% decrease year-over-year (Q4 2023).

What is REGENXBIO’s revenue growth rate?

REGENXBIO's revenue growth rate for the last 3 years (2022-2024) was -26.08%, and for the last 5 years (2020-2024) was -46.09%.

What are REGENXBIO’s revenue streams?

REGENXBIO's revenue streams in c 24 are License and Service

What is REGENXBIO’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of REGENXBIO was License and Service. This segment made a revenue of $83.33M, representing 100.00% of the company's total revenue.